Methanone, (2-chloro-3-(trifluoromethyl)phenyl)((4R)-1-(5-fluoro-2-pyrimidinyl)-1,4,6,7-tetrahydro-4-methyl-5H-1,2,3-triazolo(4,5-C)pyridin-5-yl)-

JNJ-54175446 is a research compound being investigated in clinical trials as a brain-permeable P2X7 antagonist. It is studied for its effects on amyloid biomarkers and cytokine profiles in the cerebrospinal fluid and plasma of healthy participants.